The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that ...

Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among ...

Let’s get straight to the point: a good nurse can change your experience with cancer and cancer treatment.

Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.

The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...

It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden ...

Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...

The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...